Literature DB >> 29058819

Involvement of dying beta cell originated messenger molecules in differentiation of pancreatic mesenchymal stem cells under glucotoxic and glucolipotoxic conditions.

Selda Gezginci-Oktayoglu1, Evren Onay-Ucar2, Serap Sancar-Bas1, Ayse Karatug-Kacar1, Emine S N Arda2, Sehnaz Bolkent1.   

Abstract

Beta cell mass regulation represents a critical issue for understanding and treatment of diabetes. The most important process in the development of diabetes is beta cell death, generally induced by glucotoxicity or glucolipotoxicity, and the regeneration mechanism of new beta cells that will replace dead beta cells is still not fully understood. The aim of this study was to investigate the generation mechanism of new beta cells by considering the compensation phase of type 2 diabetes mellitus. In this study, pancreatic islet derived mesenchymal stem cells (PI-MSCs) were isolated from adult rats and characterized. Then, beta cells isolated from rats were co-cultured with PI-MSCs and they were exposed to glucotoxicity, lipotoxicity and glucolipotoxicity conditions for 72 hr. As the results apoptotic and necrotic cell death were increased in both PI-MSCs and beta cells especially by the exposure of glucotoxic and glucolipotoxic conditions to the co-culture systems. Glucotoxicity induced-differentiated beta cells were functional due to their capability of insulin secretion in response to rising glucose concentrations. Moreover, beta cell proliferation was induced in the glucotoxicity-treated co-culture system whereas suppressed in lipotoxicity or glucolipotoxicity-treated co-culture systems. In addition, 11 novel proteins, that may release from dead beta cells and have the ability to stimulate PI-MSCs in the direction of differentiation, were determined in media of glucotoxicity or glucolipotoxicity-treated co-culture systems. In conclusion, these molecules were considered as important for understanding cellular mechanism of beta cell differentiation and diabetes. Thus, they may be potential targets for diagnosis and cellular or therapeutic treatment of diabetes.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  beta cell death; differentiation; pancreatic islet derived mesenchymal stem cell; secretome; signaling molecules

Mesh:

Substances:

Year:  2017        PMID: 29058819     DOI: 10.1002/jcp.26242

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  3 in total

1.  Metformin induces mitochondrial remodeling and differentiation of pancreatic progenitor cells into beta-cells by a potential mechanism including suppression of the T1R3, PLCβ2, cytoplasmic Ca+2, and AKT.

Authors:  Ertan Celik; Merve Ercin; Sehnaz Bolkent; Selda Gezginci-Oktayoglu
Journal:  J Physiol Biochem       Date:  2022-07-30       Impact factor: 5.080

2.  Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model.

Authors:  Serbay Ozkan; Basak Isildar; Merve Ercin; Selda Gezginci-Oktayoglu; Dildar Konukoglu; Neşet Neşetoğlu; Mahmut Oncul; Meral Koyuturk
Journal:  Stem Cell Res Ther       Date:  2022-09-02       Impact factor: 8.079

3.  Elevated Serum Level of Cytokeratin 18 M65ED Is an Independent Indicator of Cardiometabolic Disorders.

Authors:  Lingling Qian; Lei Zhang; Liang Wu; Jing Zhang; Qichen Fang; Xuhong Hou; Qiongmei Gao; Huating Li; Weiping Jia
Journal:  J Diabetes Res       Date:  2020-03-31       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.